Prognostic impact of fibrinogen in carotid atherosclerosis - Nonspecific indicator of inflammation or independent predictor of disease progression?

被引:57
作者
Sabeti, S
Exner, M
Mlekusch, W
Amighi, J
Quehenberger, P
Rumpold, H
Maurer, G
Minar, E
Wagner, O
Schillinger, M
机构
[1] Univ Vienna, Dept Angiol, A-1090 Vienna, Austria
[2] Univ Vienna, Dept Med & Chem Lab Diagnost, A-1090 Vienna, Austria
[3] Univ Vienna, Dept Cardiol, A-1090 Vienna, Austria
关键词
carotid stenosis; ultrasonography; inflammation;
D O I
10.1161/01.STR.0000169931.96670.fc
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background - Fibrinogen is a key factor in the coagulation cascade, it exhibits proinflammatory properties, and it is suggested to play a pivotal role in atherogenesis. We investigated whether fibrinogen predicts future progression of carotid atherosclerosis, analyzing whether fibrinogen levels add to the prognostic information of other inflammatory parameters. Methods - We prospectively studied 1268 consecutive patients without recent ( 12 months) symptoms from cerebrovascular disease. Patients underwent serial ultrasound investigations in 6- to 9-month intervals, categorizing carotid arteries as 0 % to 29 %, 30 % to 49 %, 50 % to 69 %, 70 % to 89 %, or 90 % to 99 % stenosed, or occluded. Fibrinogen levels were determined at baseline and follow-up. The risk for progressive carotid atherosclerosis according to fibrinogen levels was calculated, adjusting for traditional risk factors and other inflammatory parameters (C-reactive protein and serum amyloid A). Results - Progression of carotid atherosclerosis was found in 117 of 1268 patients (9.2 %) after a median of 8 months ( range 6 to 18). Adjusted hazard ratios for atherosclerosis progression with increasing quartiles of baseline fibrinogen were 1.83 ( P = 0.037), 2.09 (P = 0.008), and 2.45 (P = 0.002), respectively, compared with the lowest quartile. Fibrinogen at follow-up also was associated with progressive disease (P = 0.004). However, additionally adjusting for other inflammatory parameters diminished these associations to a nonsignificant level. Conclusion - Elevated fibrinogen, reflecting the level of inflammatory activity, is associated with progression of carotid atherosclerosis, as it was demonstrated previously for other inflammatory parameters. However, this association seemsto be nonspecifically related to the extent of the inflammatory process in atherosclerotic disease rather than to specific properties of fibrinogen.
引用
收藏
页码:1400 / 1404
页数:5
相关论文
共 22 条
[1]   Relevance of carotid stenosis progression as a predictor of ischemic neurological outcomes [J].
Bertges, DJ ;
Muluk, V ;
Whittle, J ;
Kelley, M ;
MacPherson, DS ;
Muluk, SC .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (19) :2285-2289
[2]  
ERIKSSON H, 1992, FIBRINOGEN NEW CARDI
[3]  
FATAH K, 1992, THROMB HAEMOSTASIS, V68, P130
[4]   Fibrinogen regulates the expression of inflammatory chemokines through NF-κB activation of endothelial cells [J].
Guo, M ;
Sahni, SK ;
Sahni, A ;
Francis, CW .
THROMBOSIS AND HAEMOSTASIS, 2004, 92 (04) :858-866
[5]   Regulation by fibrinogen and its products of intercellular adhesion molecule-1 expression in human saphenous vein endothelial cells [J].
Harley, SL ;
Sturge, J ;
Powell, JT .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (03) :652-658
[6]   FIBRINOGEN AND RISK OF CARDIOVASCULAR-DISEASE - THE FRAMINGHAM-STUDY [J].
KANNEL, WB ;
WOLF, PA ;
CASTELLI, WP ;
DAGOSTINO, RB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 258 (09) :1183-1186
[7]   Fibrinogen predicts ischaemic stroke and advanced atherosclerosis but not echolucent, rupture-prone carotid plaques - The Copenhagen City Heart Study [J].
Kofoed, SC ;
Wittrup, HH ;
Sillesen, H ;
Nordestgaard, BG .
EUROPEAN HEART JOURNAL, 2003, 24 (06) :569-578
[8]   Intraplaque hemorrhage and progression of coronary atheroma [J].
Kolodgie, FD ;
Gold, HK ;
Burke, AP ;
Fowler, DR ;
Kruth, HS ;
Weber, DK ;
Farb, A ;
Guerrero, LJ ;
Hayase, M ;
Kutys, R ;
Narula, J ;
Finn, AV ;
Virmani, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (24) :2316-2325
[9]   FIBRINOGEN AND SILENT ATHEROSCLEROSIS IN SUBJECTS WITH CARDIOVASCULAR RISK-FACTORS [J].
LEVENSON, J ;
GIRAL, P ;
RAZAVIAN, M ;
GARIEPY, J ;
SIMON, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (09) :1263-1268
[10]   Inflammation and atherosclerosis [J].
Libby, P ;
Ridker, PM ;
Maseri, A .
CIRCULATION, 2002, 105 (09) :1135-1143